徐慧芳,陈 琼,刘 茵.2017年河南省女性乳腺癌流行现状及2010—2017年变化趋势[J].中国肿瘤,2022,31(1):31-36.
2017年河南省女性乳腺癌流行现状及2010—2017年变化趋势
Incidence and Mortality of Female Breast Cancer in Henan Province in 2017 and the Trends from 2010 to 2017
中文关键词  修订日期:2021-10-19
DOI:10.11735/j.issn.1004-0242.2022.01.A002
中文关键词:  乳腺癌  女性  发病率  死亡率  变化趋势  河南
英文关键词:breast cancer  female  incidence  mortality  trend  Henan
基金项目:河南省科技攻关计划项目(202102310107)
作者单位
徐慧芳 郑州大学附属肿瘤医院河南省肿瘤医院河南省肿瘤防控工程研究中心河南省肿瘤预防国际联合实验室 
陈 琼 郑州大学附属肿瘤医院河南省肿瘤医院河南省肿瘤防控工程研究中心河南省肿瘤预防国际联合实验室 
刘 茵 郑州大学附属肿瘤医院河南省肿瘤医院河南省肿瘤防控工程研究中心河南省肿瘤预防国际联合实验室 
摘要点击次数: 1293
全文下载次数: 326
中文摘要:
      摘 要:[目的] 分析2017年河南省女性乳腺癌的发病和死亡情况及2010—2017年间河南省女性乳腺癌的流行趋势。[方法] 从质控合格的河南省2017年肿瘤登记数据中抽取女性乳腺癌病例。结合2017年河南省户籍人口数据,估计2017年河南省女性乳腺癌的发病和死亡情况。按照城乡和年龄分层,计算相应的粗发病率、粗死亡率、中国人口标化率(中标率)、世界人口标化率(世标率)、0~74岁累积率等指标。根据2010年至2017年的女性乳腺癌中标发病率和死亡率数据分析乳腺癌的流行趋势变化。[结果] 据估计,2017年河南省有20 861例女性乳腺癌新发病例,5 299例死亡。2017年河南省女性乳腺癌粗发病率为40.05/10万,中标发病率为32.20/10万,世标发病率为30.05/10万,0~74岁累积发病率为3.19%。城市和农村地区的乳腺癌中标发病率分别为35.18/10万和30.88/10万。2017年河南省女性乳腺癌粗死亡率为10.17/10万,中标死亡率为7.61/10万,世标死亡率为7.40/10万,0~74岁累积死亡率为0.85%。城市和农村地区的乳腺癌中标死亡率分别为8.06/10万和7.42/10万。2010年至2017年期间,河南省女性乳腺癌发病率和死亡率变化均无统计学意义(发病率:APC=0.6%,P=0.6;死亡率:APC=-2.5%,P=0.2)。[结论] 河南省女性乳腺癌防控形势严峻,应加大一级预防与二级预防策略的实施力度,减轻其对女性健康的危害。
英文摘要:
      Abstract:[Purpose] To analyze the incidence and mortality of female breast cancer in Henan Province in 2017 and its trend of changes during 2010—2017. [Methods] Data of new cases and deaths of female breast cancer of 2017 in Henan were collected and assessed for analysis. Based on registered population data of Henan Province in 2017, the incidence and mortality of female breast cancer in Henan Province were estimated. Stratified by areas and age, the crude incidence/mortality rates, age-standardized incidence/mortality rates by Chinese standard population in 2000(ASIRC, ASMRC), age-standardized incidence/mortality rates by Segi’s population(ASIRW, ASMRW), cumulative incidence/mortality rates(0~74 years old) were calculated. The trends of changes were also evaluated based on the age-standardized incidence and mortality from 2010 to 2017. [Results] In 2017, the estimated new cases and deaths of female breast cancer were 20 861 and 5 299, respectively in Henan Province. The crude incidence was 40.05/105. The ASIRC and ASIRW were 32.20/105 and 30.05/105, respectively. The cumulative incidence rate(0~74 years old) was 3.19%. The ASIRC in urban and rural areas was 35.18/105 and 30.88/105, respectively. In 2017, the crude mortality of female breast cancer was 10.17/105. The ASMRC and ASMRW were 7.61/105 and 7.40/105, respectively. The cumulative mortality rate(0~74 years old) was 0.85%. The ASMRC in urban and rural areas was 8.06/105 and 7.42/105, respectively. The trend of incidence and mortality of female breast cancer had no significant differences(incidence: APC=0.6%, P=0.6; mortality: APC=-2.5%, P=0.2) in Henan Province from 2010 to 2017. [Conclusion] The prevention and control situation of female breast cancer is severe in Henan Province. It is urgent to establish and implement primary and secondary prevention and control strategies.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器